मूलभूत आँकड़े
| CIK | 1493137 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Lifeloc Technologies, Inc.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| September 2, 2025 |
Exhibit 10.1 |
|
| September 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 (August 26, 2025) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of inc |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2025 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commiss |
|
| August 11, 2025 |
Lifeloc Reports Second Quarter 2025 Results Exhibit 99.1 Lifeloc Reports Second Quarter 2025 Results WHEAT RIDGE, Colo., August 11, 2025 - Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended June 30, 2025. Second Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.219 million in the |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| June 6, 2025 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2025 (June 4, 2025) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporati |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Lifeloc Technologies, Inc. (Exact name of the registrant as specified in its charter) Colorado (State or other jurisdiction of incorporation) 000-54319 (Commission file number) 12441 W 49th Ave., Suite 4, Wheat Ridge, Colorado (Address of principle executive offices) 80033 (Zip code) Eric |
|
| May 30, 2025 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form. Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2024 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 16, 2025 |
Lifeloc Reports First Quarter 2025 Results EXHIBIT 99.1 Lifeloc Reports First Quarter 2025 Results WHEAT RIDGE, Colo., May 15, 2025 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2025. First Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.277 million result |
|
| May 16, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2025 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 1, 2025 |
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1 ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1 ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6( |
|
| April 28, 2025 |
Correspondence Lifeloc Technologies, Inc. 12441 West 49TH Ave Unit #4 Wheat Ridge, CO, 80033 April 28, 2025 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jane Park Re: Lifeloc Technologies, Inc. Registration Statement on Form S-4 (File No. 333-286647) Request for Acceleration of Effectiveness Dear Ms. Park: Pursuant to |
|
| April 18, 2025 |
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 18, 2025 |
Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Lifeloc Technologies, Inc. |
|
| April 18, 2025 |
As filed with the Securities and Exchange Commission on April 18, 2025 As filed with the Securities and Exchange Commission on April 18, 2025 Registration No. |
|
| March 31, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2025 (March 28, 2025) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorpo |
|
| March 31, 2025 |
Lifeloc Reports 2024 Full Year Results Exhibit 99.1 Lifeloc Reports 2024 Full Year Results WHEAT RIDGE, Colo., March 28, 2025 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2024 fiscal year ended December 31, 2024. 2024 Financial Highlights Lifeloc Technologies posted annual net revenue of $8.538 million resulting |
|
| March 28, 2025 |
Exhibit 10.7 AMENDMENT No. 2 LICENSE AGREEMENT No. 15-C02736 between NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC and LIFELOC TECHNOLOGIES, INC. National Technology & Engineering Solutions of Sandia, LLC (NTESS), a Delaware limited liability company and Lifeloc Technologies, Inc., a Colorado corporation, entered into License Agreement #15-C02736 executed on August 29, 2016 (Agreement |
|
| March 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| March 28, 2025 |
Deed of Trust, between Citywide Banks and Lifeloc Technologies, Inc., dated September 30, 2021 Exhibit 10.9 |
|
| March 28, 2025 |
Exhibit 10.8 |
|
| March 28, 2025 |
Lifeloc Technologies, Inc. Option Agreement with Dr. Wayne Willkomm, Ph.D., dated March 31, 2021 Exhibit 10.4 LIFELOC TECHNOLOGIES, INC. OPTION AGREEMENT (INCENTIVE STOCK OPTION) THIS AGREEMENT is made and entered into this 13th day of March, 2021, by and between Lifeloc Technologies, Inc. (the "Company") and Wayne Willkomm (the "Optionee") (together, the "Parties"). RECITALS: A. On March 21, 2013, the Board of Directors of the Company adopted a Stock Option Plan (the "Plan"), which was ratif |
|
| March 28, 2025 |
Exhibit 19.1 LIFELOC TECHNOLOGIES, INC. INSIDER TRADING POLICY I. PURPOSE This Policy provides guidelines to employees, officers and directors of and consultants to Lifeloc Technologies Inc. (the “Company”) with respect to transactions in the Company’s securities. II. DEFINITIONS: a. Insider: All officers of the Company, all members of the Company’s Board of Directors, and all employees of, and co |
|
| March 28, 2025 |
Exhibit 10.6 AMENDMENT No. 1 to LICENSE AGREEMENT No. 15-C02736 between NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC and LIFELOC TECHNOLOGIES, INC. Sandia Corporation and Lifeloc Technologies, Inc., a Colorado corporation, entered into License Agreement #15-C02736 executed on August 29, 2016 (Agreement). Sandia Corporation has changed its name to National Technology & Engineering Sol |
|
| March 28, 2025 |
Exhibit 10.5 EXCLUSIVE PATENT LICENSE No. 15-C02736 SANDIA CORPORATION and LIFELOC TECHNOLOGIES, INC. This License is between Sandia Corporation ("Sandia"), manager and operator of Sandia National Laboratories for the United States Department of Energy (hereinafter "DOE") under contract DE-AC04-94AL85000, a Delaware corporation whose principal place of business is located in Albuquerque, New Mexic |
|
| March 28, 2025 |
Form of Standard Distribution Agreement Exhibit 10.1 CERTIFIED WORKPLACE DISTRIBUTION AGREEMENT LIFELOC EQUIPMENT DISTRIBUTOR Certified Workplace This agreement (the Agreement) dated by and between DBA A (check one): Corporation: Partnership Proprietorship Individual having its primary place of business at: Lifeloc Technologies, Inc. (the Company) having its place of business at: 12441 West 49th Ave., Suite 4, Wheat Ridge, CO 80033 Wher |
|
| January 7, 2025 |
Lifeloc 8.25% Subordinated Debenture, dated December 31, 2024 Exhibit 10.2 Subordinated Debenture THIS SUBORDINATED DEBENTURE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT COVERING THIS SECURITY UNDER THE ACT AND ANY R |
|
| January 7, 2025 |
Warrant to Purchase Shares of Common Stock, dated December 31, 2024 Exhibit 10.3 NEITHER THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER REGULATION D PROMULGATED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXC |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2025 (December 31, 2024) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of inc |
|
| January 7, 2025 |
Lifeloc Technologies Secures $750,000 Financing to Support Growth and Innovation Exhibit 99.1 Lifeloc Technologies Secures $750,000 Financing to Support Growth and Innovation Wheat Ridge, CO – January 7, 2025 – Lifeloc Technologies, Inc. (OTC: LCTC), a leading provider of portable breath alcohol testing devices and related solutions, today announced the successful closing of a $750,000 financing transaction through a subordinated debenture agreement with Diamond Bridge Capital |
|
| January 7, 2025 |
Subordinated Debenture Purchase Agreement, dated December 31, 2024 Exhibit 10.1 Subordinated Debenture Purchase Agreement This Subordinated Debenture Purchase Agreement (this “Agreement”) is dated as of December 31, 2024, and is made by and between Lifeloc Technologies, Inc., a Colorado corporation (“Borrower”), and Diamond Bridge Capital, LP, a Delaware limited partnership (“Lender”). Recitals A.Borrower has requested that Lender make a loan to Borrower of Seven |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| November 12, 2024 |
Lifeloc Reports Third Quarter 2024 Results Exhibit 99.1 Lifeloc Reports Third Quarter 2024 Results WHEAT RIDGE, Colo., November 12, 2024 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended September 30, 2024. Third Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.087 million in |
|
| November 12, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commi |
|
| November 12, 2024 |
Subscription Agreement by and between Lifeloc Technologies, Inc. and EDCO Partners LLLP Exhibit 10.1 Subscription Agreement THE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN. THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS O |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 8, 2024 |
Lifeloc Reports Second Quarter 2024 Results Exhibit 99.1 Lifeloc Reports Second Quarter 2024 Results WHEAT RIDGE, Colo., August 8, 2024 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended June 30, 2024. Second Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.387 million in the se |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commissi |
|
| July 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2024 (July 22, 2024) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorpora |
|
| July 26, 2024 |
Lifeloc Technologies, Inc. Appoints Adam Kashenberg to its Board of Directors Exhibit 99.1 Lifeloc Technologies, Inc. Appoints Adam Kashenberg to its Board of Directors July 26, 2024 WHEAT RIDGE, CO / ACCESSWIRE / [DATE]: Lifeloc Technologies, Inc. (OTC PINK:LCTC)(the “Company”), a global leader in the development and manufacturing of breath alcohol testing devices, has announced the appointment of Adam Kashenberg, president and CEO of Colorado Biolabs, Inc., to its Board o |
|
| July 26, 2024 |
Subscription Agreement, dated July 23, 2024 Exhibit 10.1 Subscription Agreement THE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN. THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS O |
|
| June 24, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2024 (June 19, 2024) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorpora |
|
| May 31, 2024 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form. Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2023 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Lifeloc Technologies, Inc. (Exact name of the registrant as specified in its charter) Colorado (State or other jurisdiction of incorporation) 000-54319 (Commission file number) 12441 W 49th Ave., Suite 4, Wheat Ridge, Colorado (Address of principle executive offices) 80033 (Zip code) Eric |
|
| May 23, 2024 |
Letter from GreenGrowth CPA’s dated May 22, 2024 EXHIBIT 16.1 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Lifeloc Technologies, Inc. File Reference No: 000-54319 We were previously the independent registered public accounting firm for Lifeloc Technologies, Inc. (the “Company”). On May 20th, 2024, the Company dismissed us as its independent registered public accounting firm. We hav |
|
| May 23, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2024 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 15, 2024 |
Lifeloc Reports First Quarter 2024 Results Exhibit 99.1 Lifeloc Reports First Quarter 2024 Results WHEAT RIDGE, Colo., May 15, 2024 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2024. First Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.153 million result |
|
| May 15, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2024 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| April 24, 2024 |
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 2, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commissio |
|
| April 2, 2024 |
Lifeloc Reports 2023 Full Year Results Exhibit 99.1 Lifeloc Reports 2023 Full Year Results WHEAT RIDGE, Colo., April 1, 2024 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2023 fiscal year ended December 31, 2023. 2023 Financial Highlights Lifeloc Technologies posted annual net revenue of $9.330 million resulting i |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| November 8, 2023 |
Lifeloc Reports Third Quarter 2023 Results Exhibit 99.1 Lifeloc Reports Third Quarter 2023 Results WHEAT RIDGE, Colo., November 8, 2023 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended September 30, 2023. Third Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.696 million in t |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| November 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commis |
|
| October 23, 2023 |
Letter from Gries & Associates, LLC EXHIBIT 16.1 Gries & Associates, LLC Certified Public Accountants 501 S. Cherry Street Ste 1100 Denver, Colorado 80246 October 20, 2023 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously contracted as the auditors of Lifeloc Technologies Inc. (the Company) and issued financial statements for the years ended December 31, 2022 and 2021, and the subsequ |
|
| October 23, 2023 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commi |
|
| October 19, 2023 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commiss |
|
| October 19, 2023 |
EXHIBIT 16.1 Gries & Associates, LLC Certified Public Accountants 501 S. Cherry Street Ste 1100 Denver, Colorado 80246 October 9, 2023 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously contracted as the auditors of Lifeloc Technologies Inc. (the Company) and issued financial statements for the years ended December 31, 2022 and 2021, and the subseque |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2023 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commissi |
|
| August 7, 2023 |
Lifeloc Reports Second Quarter 2023 Results Exhibit 99.1 Lifeloc Reports Second Quarter 2023 Results WHEAT RIDGE, Colo., August 4, 2023 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended June 30, 2023. Second Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.280 million in the se |
|
| May 31, 2023 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form. Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2021 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Lifeloc Technologies, Inc. (Exact name of the registrant as specified in its charter) Colorado (State or other jurisdiction of incorporation) 000-54319 (Commission file number) 12441 W 49th Ave., Suite 4, Wheat Ridge, Colorado (Address of principle executive offices) 80033 (Zip code) Eric |
|
| May 18, 2023 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2023 (May 17, 2023) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporati |
|
| May 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 9, 2023 |
Lifeloc Reports First Quarter 2023 Results Exhibit 99.1 Lifeloc Reports First Quarter 2023 Results WHEAT RIDGE, Colo., May 09, 2023 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2023. First Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.165 million result |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| April 12, 2023 |
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| March 14, 2023 |
Lifeloc Reports 2022 Full Year Results Exhibit 99.1 Lifeloc Reports 2022 Full Year Results WHEAT RIDGE, Colo., March 14, 2023 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2022 fiscal year ended December 31, 2022. 2022 Financial Highlights Lifeloc Technologies posted annual net revenue of $8.482 million resulting |
|
| March 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2023 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commissi |
|
| November 14, 2022 |
Lifeloc Reports Third Quarter 2022 Results Exhibit 99.1 Lifeloc Reports Third Quarter 2022 Results WHEAT RIDGE, Colo., November 10, 2022 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the third quarter ended September 30, 2022. Third Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.032 milli |
|
| November 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 (November 10, 2022) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of i |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| August 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 10, 2022 |
Lifeloc Reports Second Quarter 2022 Results Exhibit 99.1 Lifeloc Reports Second Quarter 2022 Results WHEAT RIDGE, Colo., August 9, 2022 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the second quarter ended June 30, 2022. First Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.180 million in |
|
| August 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2022 (August 9, 2022) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorp |
|
| June 3, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2022 (June 1, 2022) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 27, 2022 |
Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2021 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 27, 2022 |
SD 1 lifelocsd.htm FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Lifeloc Technologies, Inc. (Exact name of registrant as specified in its charter) Colorado 000-54319 (State or other jurisdiction of incorporation or organization) (Commission File Number) 12441 W 49th Ave., Suite 4, Wheat Ridge, Colorado 80033 (Address of princi |
|
| May 12, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 (May 11, 2022) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 12, 2022 |
Lifeloc Reports First Quarter 2022 Results Exhibit 99.1 Lifeloc Reports First Quarter 2022 Results WHEAT RIDGE, Colo., May 11, 2022 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2022. First Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.161 million result |
|
| May 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| April 25, 2022 |
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A 1 lclcdef14a.htm DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commis |
|
| March 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| March 3, 2022 |
Loan Agreement with Citywide Banks (Term Loan), dated September 30, 2021 Exhibit 10.2 |
|
| February 23, 2022 |
Lifeloc Reports 2021 Full Year Results Exhibit 99.1 Lifeloc Reports 2021 Full Year Results WHEAT RIDGE, Colo., February 22, 2022 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2021 fiscal year ended December 31, 2021. 2021 Financial Highlights Lifeloc Technologies posted annual net revenue of $7.054 million resulti |
|
| February 23, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2022 (February 22, 2022) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) ( |
|
| October 29, 2021 |
Lifeloc Reports Third Quarter 2021 Results EX-99.1 2 ex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Reports Third Quarter 2021 Results WHEAT RIDGE, Colo., October 28, 2021 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the third quarter ended September 30, 2021. Third Quarter Financial Highlights Lifeloc posted quar |
|
| October 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| August 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2021 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| August 6, 2021 |
Lifeloc Reports Second Quarter 2021 Results EX-99.1 2 ex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Reports Second Quarter 2021 Results WHEAT RIDGE, Colo., August 6, 2021 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the second quarter ended June 30, 2021. Second Quarter Financial Highlights Lifeloc posted quarterl |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| June 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 14, 2021 |
Exhibit 16.1 |
|
| May 28, 2021 |
EX-1.01 2 ex101.htm EXHIBIT 1.01 CONFLICT MINERALS REPORT OF LIFELOC TECHNOLOGIES, INC. Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2020 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exch |
|
| May 28, 2021 |
SD 1 lifelocsd.htm FORM SD OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2021 Estimated average burden hours per response.... 480.61 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Lifeloc Technologies, Inc. (Exact name of registrant as specified in its charter) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in |
|
| May 13, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 lifeloc8k-051221.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2021 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incor |
|
| May 13, 2021 |
Lifeloc Reports First Quarter 2021 Results Exhibit 99.1 Lifeloc Reports First Quarter 2021 Results WHEAT RIDGE, Colo., May 12, 2020 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2021. First Quarter Financial Highlights Lifeloc posted quarterly net revenue of $1.810 million result |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 11, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2021 (May 10, 2021) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| April 6, 2021 |
DEFR14A 1 lifelocdef14a.htm DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Co |
|
| April 1, 2021 |
DEF 14A 1 lifelocdef14a.htm DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com |
|
| March 31, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 lifeloc8k-033121.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2021 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of inc |
|
| March 31, 2021 |
Lifeloc Reports 2020 Full Year Results EX-99.1 2 life99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Reports 2020 Full Year Results WHEAT RIDGE, Colo., March 30, 2021 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2020 fiscal year ended December 31, 2020. 2020 Financial Highlights Lifeloc Technologies posted annual net |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| November 12, 2020 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 11, 2020 LIFELOC TECHNOLOGIES, INC. |
|
| November 12, 2020 |
Lifeloc Reports Third Quarter 2020 Results Exhibit 99.1 Lifeloc Reports Third Quarter 2020 Results WHEAT RIDGE, Colo., Nov. 11, 2020 /PRNewswire/ - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the third quarter and for the nine months ended September 30, 2020. Third Quarter Financial Highlights Lifeloc posted quar |
|
| September 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2020 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Num |
|
| August 17, 2020 |
Lifeloc Reports Second Quarter 2020 Results EX-99.1 2 ex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Reports Second Quarter 2020 Results WHEAT RIDGE, Colo., August 13, 2020 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the second quarter and for the six months ended June 30, 2020. Second Quarter Financial Highlights |
|
| August 17, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2020 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| July 16, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2020 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 16, 2020 |
Study Shows No Detectable Chance of Catching Virus from Breath Alcohol Test Exhibit 99.1 Study Shows No Detectable Chance of Catching Virus from Breath Alcohol Test WHEAT RIDGE, Colo., July 14, 2020 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced the results of a study aimed at determining risk of subject to subject virus transmission through their FC Series (Phoenix 6 |
|
| July 8, 2020 |
10-Q/A 1 lifeloc10q-033120.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro |
|
| July 8, 2020 |
Correspondence July 8, 2020 Mr. Gary Newberry Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission Washington, D.C. 20549 Re: Letter dated July 6, 2020 Dear Mr. Newberry: Form 10-K for the Fiscal Year Ended December 31, 2019 Note 2. Summary of Significant Accounting Policies Inventories, page 26 1. We define market as net realizable value, which is consistent |
|
| May 29, 2020 |
Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2019 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 29, 2020 |
OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2020 Estimated average burden hours per response. |
|
| May 19, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2020 (May 18, 2020) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission |
|
| May 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 13, 2020 |
Lifeloc Reports First Quarter 2020 Results EX-99.1 2 ex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Reports First Quarter 2020 Results WHEAT RIDGE, Colo., May 13, 2020 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2020. First Quarter Financial Highlights We posted quarterly net rev |
|
| May 13, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2020 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 5, 2020 |
PPP Promissory Note dated May 1, 2020 EX-10.1 2 ex10x1.htm EXHIBIT 10.1 Exhibit 10.1 |
|
| May 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2020 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| April 2, 2020 |
LCTC / Lifeloc Technologies, Inc. DEF 14A - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 24, 2020 |
LCTC / Lifeloc Technologies, Inc. 10-K - Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| March 17, 2020 |
Lifeloc Reports 2019 Full Year Results Exhibit 99.1 Lifeloc Reports 2019 Full Year Results WHEAT RIDGE, Colo., March 17, 2020 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2019 fiscal year ended December 31, 2019. 2019 Financial Highlights Lifeloc Technologies posted annual net revenue of $8.752 million resulting |
|
| March 17, 2020 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| February 5, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2020 (January 30, 2020) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Co |
|
| February 5, 2020 |
EX-99.1 2 ex99x1.htm EXHIBIT 99.1 Exhibit 99.1 Lifeloc Technologies Achieves Reference Material Producer Accreditation for Alcohol Simulator Solution WHEAT RIDGE, Colo. (BusinessWire) January 30, 2020 - Lifeloc Technologies, a leading manufacturer and worldwide provider of Evidential and Preliminary Breath Testers (PBT) and Calibration Supplies is pleased to announce ISO 17034:2016 accreditation o |
|
| November 12, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2019 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 12, 2019 |
Lifeloc Reports Third Quarter 2019 Results Exhibit 99.1 Lifeloc Reports Third Quarter 2019 Results WHEAT RIDGE, Colo., November 12, 2019 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the third quarter ended September 30, 2019. Third Quarter Highlights Lifeloc posted quarterly net revenue of $2.258 million resulti |
|
| November 8, 2019 |
LCTC / Lifeloc Technologies, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| August 12, 2019 |
LCTC / Lifeloc Technologies, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 8, 2019 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2019 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| August 8, 2019 |
Lifeloc Reports Second Quarter 2019 Results Exhibit 99.1 Lifeloc Reports Second Quarter 2019 Results WHEAT RIDGE, Colo., August 7, 2019 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the second quarter ended June 30, 2019. Second Quarter Highlights Lifeloc posted quarterly net revenue of $2.34 million resulting in |
|
| May 31, 2019 |
LCTC / Lifeloc Technologies, Inc. SD - - FORM SD OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2020 Estimated average burden hours per response. |
|
| May 31, 2019 |
Exhibit 1.01 — Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form. Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2018 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 30, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2019 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 30, 2019 |
Lifeloc Reports First Quarter 2019 and Shareholder Vote Results Exhibit 99.1 Lifeloc Reports First Quarter 2019 and Shareholder Vote Results WHEAT RIDGE, Colo., May 17, 2019 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the first quarter ended March 31, 2019, as well as the results for the 2019 annual shareholder meeting. First Quart |
|
| May 8, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2019 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| May 7, 2019 |
LCTC / Lifeloc Technologies, Inc. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| March 26, 2019 |
LCTC / Lifeloc Technologies, Inc. DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 21, 2019 |
Lifeloc Reports 2018 Full Year Results and DWAC/FAST Eligibility Exhibit 99.1 Lifeloc Reports 2018 Full Year Results and DWAC/FAST Eligibility WHEAT RIDGE, Colo., March 15, 2019 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2018 fiscal year ended December 31, 2018. 2018 Financial Highlights Lifeloc Technologies posted annual net revenue of |
|
| March 21, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2018 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 18, 2019 |
LCTC / Lifeloc Technologies, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| January 25, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2019 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| January 25, 2019 |
Exhibit 10.1 FIRST AMENDMENT TO THE AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "Amendment") is made and entered into effective this 25th day of January, 2019 (the "Effective Date") by and between Lifeloc Technologies, Inc. (the "Company"), and Wayne Willkomm ("Executive"). Executive and the Company are referred to |
|
| November 19, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2018 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 19, 2018 |
Lifeloc Reports Third Quarter 2018 Results Exhibit 99.1 Lifeloc Reports Third Quarter 2018 Results WHEAT RIDGE, Colo., November 13, 2018 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the third quarter ended September 30, 2018. Third Quarter Financial Highlights We posted quarterly net revenue of $2.06 million resulting in |
|
| November 8, 2018 |
LCTC / Lifeloc Technologies, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| August 16, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2018 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 16, 2018 |
Lifeloc Reports Second Quarter 2018 Results Exhibit 99.1 Lifeloc Reports Second Quarter 2018 Results WHEAT RIDGE, Colo., August 10, 2018 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the second quarter ended June 30, 2018. Second Quarter Financial Highlights We posted quarterly net revenue of $2.13 million resulting in qua |
|
| August 9, 2018 |
LCTC / Lifeloc Technologies, Inc. FORM 10-Q (Quarterly Report) 10-Q 1 lifeloc10q-063018.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file |
|
| July 2, 2018 |
8-K 1 lifeloc8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2018 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporati |
|
| May 31, 2018 |
Exhibit 1.01 — Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2017 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 31, 2018 |
LCTC / Lifeloc Technologies, Inc. FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Lifeloc Technologies, Inc. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 12441 W 49th Ave., Suite 4, Wheat Ridge, Colorado 800 |
|
| May 29, 2018 |
Exhibit 99.1 Lifeloc Reports First Quarter 2018 Results WHEAT RIDGE, Colo., May 22, 2018 - Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the first quarter ended March 31, 2018. “This was a very productive first quarter for Lifeloc,” said President and CEO Dr. Wayne Willkomm. “We sa |
|
| May 29, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2018 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 11, 2018 |
LCTC / Lifeloc Technologies, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 7, 2018 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2018 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| April 5, 2018 |
LCTC / Lifeloc Technologies, Inc. DEFINITIVE 14A PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 23, 2018 |
LCTC / Lifeloc Technologies, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| November 14, 2017 |
LCTC / Lifeloc Technologies, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| October 10, 2017 |
Amended and Restated Employment Agreement with Dr. Wayne Willkomm, Ph.D., dated October 5, 2017 (7) Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (? Agreement?) is entered into this 6th day of October, 2017, by and between Lifeloc Technologies, Inc. (the ? Company?), and Wayne Willkomm (? Executive?). Executive and the Company are referred to individually as a ?Party? and collectively as the ?Parties.? WHEREAS, the Parties previously entered |
|
| October 10, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2017 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 14, 2017 |
LCTC / Lifeloc Technologies, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 14, 2017 |
Amendment No. 3 to Loan Agreement dated May 15, 2017 (6) Exhibit 10.1 AMENDMENT NO. 3 TO LOAN AGREEMENT This Amendment No. 3 (the "Amendment") dated as of May 15, 2017, is between Bank of America, NA. (the “Bank")- and LIFELOC TECHNOLOGIES, INC. (the “Borrower"). RECITALS A. The Bank and the Borrower entered into a certain Loan Agreement dated as of October 29, 2014 (together with any previous amendments, the "Agreement"). B. The Bank and the Borrower d |
|
| May 31, 2017 |
OMB APPROVAL OMB Number: 3235-0697 Expires: June 30, 2019 Estimated average burden hours per response. |
|
| May 31, 2017 |
Exhibit 1.01 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. ("Lifeloc") for calendar year 2016 in accordance with Rule 13p-1 ("Rule 13p-1") under the Securities Exchange Act of 1934 (the "1934 Act"). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| May 12, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 9, 2017 |
Submission of Matters to a Vote of Security Holders 8-K 1 lifeloc8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: May 1, 2017 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or |
|
| April 4, 2017 |
Amended and Restated Bylaws of Lifeloc Technologies, Inc., dated as of March 31, 2017 (4) Exhibit 3.1 LIFELOC TECHNOLOGIES, INC. BY-LAWS ARTICLE I. ? Offices The principal offices of the corporation shall initially be at Wheat Ridge, Colorado, but the board of directors, in its discretion, may keep and maintain offices wherever the business of the corporation may require. ARTICLE II. ? Meeting of Shareholders 1. Time and Place: Any meeting of the shareholders, other than the annual mee |
|
| April 4, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2017 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| April 3, 2017 |
Lifeloc Technologies DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| March 10, 2017 |
Exhibit 2.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this " Agreement") is made and entered into as of March 8, 2017, by and among Lifeloc Technologies, Inc., a Colorado corporation (hereinafter referred to as " Buyer"), and Integrated Monitoring Systems, LLC, a Colorado limited liability company (" IMS"), Track Group Inc., a Delaware corporation (" Track" and collectively with IMS |
|
| March 10, 2017 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2017 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 2, 2017 |
LIFELOC TECHNOLOGIES, INC. ARTICLE I. – Offices Exhibit 3.1 LIFELOC TECHNOLOGIES, INC. BY-LAWS ARTICLE I. ? Offices The principal offices of the corporation shall initially be at Wheat Ridge, Colorado, but the board of directors, in its discretion, may keep and maintain offices wherever the business of the corporation may require. ARTICLE II. ? Meeting of Shareholders 1. Time and Place: Any meeting of the shareholders, other than the annual mee |
|
| March 2, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2017 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 23, 2016 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2016 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 23, 2016 |
Exhibit 16.1 December 23, 2016 Securities and Exchange Commission 100 F Street Washington, DC 20549 Ladies and Gentlemen: On December 20, 2016, we were dismissed as the independent registered public accounting firm for Lifeloc Technologies, Inc. (the Company). We have read the Company's disclosure set forth in Item 4.01, "Changes in Registrant's Certifying Accountant" of the Company's Current Repo |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| August 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 31, 2016 |
ex1x02.htm Exhibit 1.02 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (?Lifeloc?) for calendar year 2015 in accordance with Rule 13p-1 (?Rule 13p-1?) under the Securities Exchange Act of 1934 (the ?1934 Act?). Please refer to Rule 13p-1, Form SD and th |
|
| May 31, 2016 |
Lifeloc Technologies SPECIALIZED DISCLOSURE REPORT lctcsd.htm OMB APPROVAL OMB Number: 3235-0697 Expires: May 31, 2016 Estimated average burden hours per response?.480.61 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Lifeloc Technologies, Inc. (Exact name of registrant as specified in its charter) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colora |
|
| May 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 9, 2016 |
Lifeloc Technologies FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: May 2, 2016 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I.R.S |
|
| March 30, 2016 |
Lifeloc Technologies DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 22, 2016 |
EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10..11 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is entered into this 5th day of January, 2016, by and between Lifeloc Technologies, Inc. (the “Company”), and Wayne Willkomm (“Executive”). Executive and the Company are referred to individually as a “Party” and collectively as the “Parties.” WHEREAS, the Parties desire to enter into this Agreement sett |
|
| March 22, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| January 22, 2016 |
POWER OF ATTORNEY Know all by these presents that the undersigned hereby constitutes and appoints Vern D. |
|
| January 20, 2016 |
Press Release for Immediate Distribution Exhibit 99.1 Press Release for Immediate Distribution January 20, 2016 Denver - Lifeloc Technologies (OTC:LCTC), a leading manufacturer and exporter of professional breath alcohol testers for use by Law Enforcement, Corrections, Schools and the Workplace, announced today that its Board of Directors has named Dr. Wayne Willkomm to the position of president and CEO of Lifeloc Technologies effective |
|
| January 20, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2016 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Number |
|
| December 29, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2015 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| November 12, 2015 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 9/30/2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| August 7, 2015 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 6/30/2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| June 2, 2015 |
ex1x02.htm Exhibit 1.02 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. ("Lifeloc") for calendar year 2014 in accordance with Rule 13p-1 ("Rule 13p-1") under the Securities Exchange Act of 1934 (the "1934 Act"). Please refer to Rule 13p-1, Form SD and th |
|
| June 2, 2015 |
Lifeloc Technologies SPECIALIZED DISCLOSURE REPORT lctcsd.htm OMB APPROVAL OMB Number: 3235-0697 Expires: May 31, 2016 Estimated average burden hours per response?.480.61 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Lifeloc Technologies, Inc. (Exact name of registrant as specified in its charter) LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colora |
|
| May 12, 2015 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 3/31/2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| April 23, 2015 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: April 20, 2015 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I. |
|
| April 1, 2015 |
Lifeloc Technologies DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 20, 2015 |
Security Agreement with Bank of America, dated October 29, 2014 (3) Exhibit 10.13 SECURITY AGREEMENT (Multiple Use) 1. THE SECURITY. The undersigned LIFELOC TECHNOLOGIES, INC. ( the "Pledgor") hereby assigns and grants to Bank of America, N.A., its successors and assigns ("BANA"), and to Bank of America Corporation and its subsidiaries and affiliates (BANA and all such secured parties, collectively, the "Bank") a security interest in the following described proper |
|
| March 20, 2015 |
Exhibit 10.10 |
|
| March 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| March 20, 2015 |
Exhibit 10.9 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement is made and entered into as of December 1, 2014, by and among Lifeloc Technologies, Inc., a Colorado corporation (hereinafter referred to as "Buyer"), Superior Training Solutions, Inc., a Texas corporation (hereinafter referred to as "Seller"), and Gary Glisan and J. Mac Allen (each a "Selling Stockholder" and together the "Sellin |
|
| March 20, 2015 |
Loan Agreement with Bank of America (Line of Credit), dated October 29, 2014 (3) Exhibit 10.14 Loan Agreement Date of Agreement: October 29, 2014 Principal Amount: $250,000.00 Account Number: 25-0001103705 Introduction. This Agreement dated and effective as of October 29, 2014, is entered into between LIFELOC TECHNOLOGIES, INC. (the "Borrower") and Bank of America, N.A. (the "Bank"). The Borrower agrees to the following terms and conditions: 1. LINE OF CREDIT 1.1 Line of Credi |
|
| March 20, 2015 |
Loan Agreement with Bank of America (Term Loan), dated October 29, 2014 (3) Exhibit 10.11 Loan Agreement Date of Agreement: October 29, 2014 Principal Amount: $1,612,981.00 Account Number: 25-0001103705 Introduction. This Agreement dated and effective as of October 29, 2014, is entered into between LIFELOC TECHNOLOGIES, INC. (the "Borrower") and Bank of America, N.A. (the "Bank"). The Borrower agrees to the following terms and conditions: 1. LOAN 1.1 Loan Amount. The Bank |
|
| March 20, 2015 |
Deed of Trust with Bank of America, dated October 29, 2014 (3) Exhibit 10.12 RECORDING REQUESTED BY AND WHEN RECORDED MAIL TO: Bank of America, N.A. Doc Retention Center CT2-515-BB-03 70 Batterson Park Road Farmington, CT 06032 Space above this line for Recorder's Use DEED OF TRUST, ASSIGNMENT OF RENTS, SECURITY AGREEMENT AND FIXTURE FILING This Deed of Trust is made as of October 29, 2014, by LIFELOC TECHNOLOGIES, INC., as trustor ("Trustor"), with an addres |
|
| January 28, 2015 |
8-K 1 lifeloc8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2015 LIFELOC TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Colorado 000-54319 84-1053680 (State or other jurisdiction of incorpor |
|
| January 28, 2015 |
Exhibit 99.1 Lifeloc Technologies Appoints G. Ravishankar to President New Lifeloc Technologies President to Focus on Operational Excellence, New Technologies and New Products in Breath Alcohol Testing and Related Sensing Markets Lifeloc Technologies (OTC:LCTC), a leading manufacturer and exporter of professional breath alcohol testers for use by Law Enforcement, Corrections, Schools and the Workp |
|
| November 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54319 LIFELOC TECHNOLO |
|
| August 28, 2014 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: August 25, 2014 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I |
|
| August 8, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54319 LIFELOC TECHNOLOGIES, |
|
| June 2, 2014 |
Exhibit 1.02 Conflict Minerals Report of Lifeloc Technologies, Inc. in Accordance with Rule 13p-1 under the Securities Exchange Act of 1934 This is the Conflict Minerals Report of Lifeloc Technologies, Inc. (“Lifeloc”) for calendar year 2013 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act |
|
| June 2, 2014 |
OMB APPROVAL OMB Number: 3235-0697 Expires: May 31, 2016 Estimated average burden hours per response…. |
|
| May 7, 2014 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 3/31/2014 10-Q 1 lifeloc10q-033114.htm FORM 10-Q FOR THE PERIOD ENDED 3/31/2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition |
|
| May 1, 2014 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: April 21, 2014 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I. |
|
| April 1, 2014 |
DEF 14A 1 lifelocdef14a.htm DEFINITIVE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Com |
|
| March 18, 2014 |
Annual Report - FORM 10-K FOR THE FISCAL YEAR ENDED 12/31/2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| November 12, 2013 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 9/30/2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOG |
|
| September 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: September 9, 2013 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of |
|
| August 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 8, 2013 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 3/31/2013 UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| May 8, 2013 |
Exhibit 10.1 LIFELOC TECHNOLOGIES, INC. STOCK OPTION PLAN I. Purpose The LIFELOC TECHNOLOGIES, INC. Stock Option Plan (the “Plan”) provides for the grant of Stock Options to employees and directors of Lifeloc Technologies, Inc. (the “Company”), and such of its subsidiaries (as defined in Section 424(f) of the Internal Revenue Code of 1986, as amended (the “Code”)) as the Board of Directors of the |
|
| April 5, 2013 |
Submission of Matters to a Vote of Security Holders - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: April 1, 2013 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I.R |
|
| March 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 15, 2013 |
Annual Report - FORM 10-K FOR THE PERIOD ENDED 12/31/2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 000-54319 LIFELOC TECHNOLOG |
|
| November 5, 2012 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 9/30/2012 UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGI |
|
| September 4, 2012 |
LIFELOC TECHNOLOGIES, INC. ARTICLE I. – Offices Exhibit 3.1 LIFELOC TECHNOLOGIES, INC. BY-LAWS ARTICLE I. – Offices The principal offices of the corporation shall initially be at Wheat Ridge, Colorado, but the board of directors, in its discretion, may keep and maintain offices wherever the business of the corporation may require. ARTICLE II. – Meeting of Shareholders 1. Time and Place: Any meeting of the shareholders, other than the annual mee |
|
| September 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: August 29, 2012 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I |
|
| August 14, 2012 |
Quarterly Report - FORM 10-Q FOR THE PERIOD ENDED 6/30/2012 UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, I |
|
| May 9, 2012 |
UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| April 17, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 21, 2012 |
Lifeloc Technologies, Inc. Condensed Balance Sheets December 31, 2011 and 2010 (Audited) Exhibit 99.1 Lifeloc Technologies Reports Full Year 2011 Results Record Revenue and Earnings Wheat Ridge, Colorado - March 20, 2012 - Lifeloc Technologies (OTC: LCTC), a leader in the manufacture of portable breath alcohol testing devices for medical, workplace, law enforcement and personal use, announced record financial results for 2011. Annual revenue increased 31.5% to $8,048,952. Net income a |
|
| March 21, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: March 20, 2012 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I. |
|
| March 16, 2012 |
Annual Report - FORM 10-K FOR THE YEAR ENDED 12/31/2011 10-K 1 lifeloc10k-123111.htm FORM 10-K FOR THE YEAR ENDED 12/31/2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the trans |
|
| February 14, 2012 |
LCTC / Lifeloc Technologies, Inc. / EDCO PARTNERS LLLP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. N/A)* Lifeloc Technologies, Inc. (Name of Issuer) Common stock, no par value (Title of Class of Securities) 53220Y207 (CUSIP Number) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: £ Rule 13d-1(b) £ Rule 13d-1(c) T R |
|
| February 10, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: February 4, 2012 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of ( |
|
| February 10, 2012 |
Lifeloc Technologies Announces Record Q4, 2011 Sales Exhibit 99.1 Lifeloc Technologies Announces Record Q4, 2011 Sales Record Q4, 2011 sales results reported by Lifeloc Technologies, a leading international provider of professional breath alcohol testers. Wheat Ridge, CO (PRWEB) February 04, 2012 Lifeloc Technologies, a leader in the manufacture of portable breath alcohol testing devices for Workplace and Law Enforcement use, today announced that ne |
|
| November 3, 2011 |
UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGI |
|
| August 24, 2011 |
Quarterly Report - FORM 10-Q/A UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q/A x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, |
|
| August 15, 2011 |
UNITED STATE SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54319 LIFELOC TECHNOLOGIES, I |
|
| July 5, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: July 5, 2011 COMMISSION FILE NO. 000-54319 (Date of earliest event reported) LIFELOC TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) COLORADO 84-1053680 (State or other jurisdiction of (I.R. |
